Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Inventory: 2023-2025

  • Zhengye Biotechnology Holding's Inventory was N/A to $7.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $7.4 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2024, which is 3.30% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Inventory stood at $7.4 million for Q2 2025, which was down 8.66% from $8.1 million recorded in Q4 2024.
  • Zhengye Biotechnology Holding's 5-year Inventory high stood at $8.1 million for Q4 2024, and its period low was $7.4 million during Q2 2025.
  • Over the past 3 years, Zhengye Biotechnology Holding's median Inventory value was $8.1 million (recorded in 2023), while the average stood at $7.9 million.
  • Data for Zhengye Biotechnology Holding's Inventory shows a peak YoY rose of 0.10% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Zhengye Biotechnology Holding's Inventory stood at $8.1 million in 2023, then rose by 0.10% to $8.1 million in 2024, then reached $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q2 2025, $8.1 million for Q4 2024, and $8.1 million during Q4 2023.